Identifying Poor Responders to STN DBS in Parkinson Disease: The Role of Rapid Disease Progression in the First Year in Optimal Responders to Levodopa

Documenti analoghi

• NIH Toolbox performance of persons with Parkinson's disease according to GBA1 and STN‐DBS status
  di: Ahmad Almelegy, et al.
  Pubblicazione: (2024)
• Diagnostic, Prognostic Value, and Pathological Associations of Levodopa Responsiveness in Parkinson's Disease, Multiple System Atrophy, and Progressive Supranuclear Palsy
  di: Vitor Maia Arca, et al.
  Pubblicazione: (2026)
• Subcutaneous Levodopa in Parkinson's Disease: A Systematic Review and Meta‐Analysis
  di: Matthew Burton, et al.
  Pubblicazione: (2026)
• Five‐Year Disease Progression in Synuclein Seeding Positive Sporadic Parkinson's Disease
  di: Paulina Gonzalez‐Latapi, et al.
  Pubblicazione: (2026)
• Predictive Value of Perivascular Space Network and Choroid Plexus for Levodopa Responsiveness in Parkinson's Disease
  di: Zekai Chen, et al.
  Pubblicazione: (2025)